Dr. Geoff Brooke
Dr. Geoff Brooke co-founded GBS in 1996 and has more than 15 years venture capital experience. He was formerly President of Medvest Inc., a US-based early-stage venture capital group he co-founded with Johnson & Johnson. Geoff’s experience includes company formation and acquisitions, as well as public listings on both NASDAQ and ASX. He has been an investor, executive and director of private and public companies and has an extensive network of international contacts. Geoff is on the board of GBS portfolio companies Antipodean Pharmaceuticals, Chemgenex Pharmaceuticals, CoDa Therapeutics, CogState, Sunshine Heart and Uptake Medical.

Geoff is licensed in clinical medicine by the Medical Board of Victoria, Australia and his post-graduate studies were in anaesthesiology/intensive care. He earned his Bachelor of Medicine/Surgery from the University of Melbourne, Australia and a Masters of Business Administration from IMEDE (now IMD) in Lausanne, Switzerland.

Eric J. Kim
Eric is a Managing Director with Maverick Capital where he focuses on the Firm’s private investments and small cap public equity investments. Prior to joining Maverick, Eric co-founded Biomimedica, an orthopedics-focused medical device start-up and was a management consultant with McKinsey & Company’s healthcare practice where he worked with a number of pharma, biotech and medical device companies.

He received his M.B.A. from Stanford’s Graduate School of Business and his Bachelors Degree in Cognitive Science from Yale University (Magna Cum Laude), where he was elected to Phi Beta Kappa and was a recipient of the Richard U. Light Fellowship.

Robert F. Kuhling
Rob Kuhling came to ONSET Ventures in 1987 after experience in a variety of technology marketing, strategic development and management positions. Rob was Director of Marketing at Sun Microsystems, where he spearheaded the company’s expansion into the design automation marketplace. He also served as VP and Manager of General Electric-Calma’s $100 million electronic design automation business and was a team leader for Boston Consulting Group, where he oversaw the development of a range of corporate business strategies.

At ONSET Ventures, Rob invests in communications and networking companies and medical device companies. Rob serves on the boards of several public and private companies, and has led ONSET Ventures’ investments in companies like Aneurx, Clarify, Conceptus, Alteon, Packeteer, Embolic Protection, Endotex Interventional Systems, Uptake Medical and Gadzoox Networks.

Rob received his A.B. from Hamilton College and his MBA from Harvard Business School.

R. King Nelson, President and CEO
King joined Uptake Medical in April 2007 with over 25 years of medical device experience including 19 years with American Hospital Supply and Baxter International. He was Division President for Dade Diagnostics, Bentley Labs and Baxter’s Perfusion Services from 1989-1999. He was CEO and President of VenPro Corporation, a medical device company focused on heart and venous valves. The heart valve business was acquired by Medtronic in 2003. Prior to joining Uptake Medical, King was CEO and President of Kerberos Proximal Solutions in 2005-2006 when FoxHollow Technologies acquired it. He serves on the Board of Directors for several early stage private medical device companies and Digirad Corporation. King graduated from Texas Tech University and has an MBA from The University of Miami.

Carl Simpson
Carl Simpson has served as a director of the Company since 2006. Carl has more than 40 years of experience in the medical/medical device industry. He is a co-founder and managing director at Coronis Medical Ventures, an early-stage medical device company incubator. For the last 32 years, Carl has been active as a medical device executive and entrepreneur, and has served on the board of directors for more than 20 medical device start-up companies. Carl began his career as a founder of Advanced Cardiovascular Systems, which eventually became part of Guidant Corporation, where he spent 21 years.

Carl received a bachelor’s degree in microbiology from San Jose State University, and graduate degrees in electrical engineering and computer science and an MBA from the University of Santa Clara.